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Out of 17 schizophrenic and 14 manic patients diagnosed according to ICD-10, 11 and 9 patients 
respectively developed acute dystonia following a single intravenous injection of 40mg haloperidol. 
The results are not statistically significant (p>0.05) suggesting that monies and schizophrenics are 
equally vulnerable to develop neuroleptic - induced acute dystonia. 
Nasrallah et al. (1988) have reported 
that manics more often suffer from neurolep-
tics-induced acute dystonic reactions than 
schizophrenics whereas other workers 
(Remington et al 1990; Keeprers and Cassey, 
1987) have found that manics and 
schizophrenics are equally susceptible to 
develop this side effect. This controversy 
prompted us to conduct this study. 
MATERIAL AND METHOD 
The patient population of this study was 
drawn from the acutely excited psychotic 
patients needing immediate neuroleptization, 
who attended the outpatient psychiatric facility 
of our hospital. Each patient was given 40mg. of 
haloperidol intravenously very slowly and 
watched for the development of acute dystonic 
reaction for three hours. We used this dose and 
three hours of observation because our initial 
observation (unpublished) has demonstrated 
40mg of haloperidol to be a safe and adequate 
dose for rapid neuroleptization and all patients 
who had to develop acute dystonic reaction with 
this dose, developed it within 102 minutes of the 
injection. During the process of injecting the 
drug, if a patient calmed down, the remaining 
amount of drug was rejected. Each patient was 
hospitalized after the observation period. In the 
wards the patients were diagnostically 
evaluated by psychistrists using the ICD-9 
criteria. The evaluating psychiatrist did not 
know the dystonic and nondystonic status of 
patients i.e. whether a given patient had 
developed acute dystonia with haloperidol in-
jection or not. 
RESULTS 
Out of 58 patients, we had to exclude 27 
patients from the final analysis. We excluded 
patients who had taken oral neuroleptics in the 
past 7 days of fluphenazine deconoate injection 
in the past one month (n = 12), patients who 
received a diagnosis other than schizophrenia, 
manic depressive psychosis-manic phase, or 
manic depressive psychosis, circular currently 
manic (n=9), patients who slept during obser-
vation period (n = 7) and patients who required 
less than 40tng of haloperidol for tranquilliza-
tion (n = 4). Some patients had more than one 
reason for their exclusion. After excluding the 
above patients, there were 17 and 14 patients in 
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schizophrenic and manic group respectively. Both 
the groups were found to be comparable in age 
and sex. Table I shows the number of dystonic 
and non-dystonic patients in the two groups. 
Table-I: Distribution of dystonic and nondystonic response in 
schizophrenic and manic group 
Response to halo 
peridol injection 
Schizophrenic group 
(n = 17) 
Manic group 
(n = 14) 
Statistical 
significance 
Dystonic 
Nondystonic 
11 
6  p = 0.64 
* Fisher's Exact Prabablity 
**Not Significant 
DISCUSSION 
Ours was a prospective study unlike the 
one by Nasrallah etal. (1988). We gave 4mg of 
haloperidol intravenouslu which shortened the 
observation period to 3 hours. Remington etal. 
(1990) used multiple, hourly injections of 
haloperidol intramuscularly (upto 70mg. in 
seven hours) because of which their observation 
period exceed two days. We believe that oc-
curence of transient dystonic rections can be 
detected better during a shorter observation 
period. In addition to this, we are able to ex-
clude all the patients who slept during observa-
tion period (because dystonia does not occur 
during sleep) whereas the same would not have 
been possible in the study by Remington et al. 
(1990) because all patients are likely to fall 
asleep during such a long observation period. 
However, exclusion of a very large number of 
patients from the study, makes our study 
population unrepresentative of the usual manic 
and schizophrenic patients attending a 
psychiatric clinic. 
We also could not exclude patients who 
had a family history of Parkinson's disease or 
other diseases with extrapyramidal manifesta-
tions because adequate and reliable family his-
tory was not available in majority of the cases. 
Since tardive dyskinesia is commoner in 
manics than schizophrenics (Hamra et al. 1983; 
Yassa et al . 1983) one might be tempted to 
extrapolate that acute dystonia also will be more 
common in manics. One has to remember that 
the underlying biochemical mechanisms 
producing tardive dyskinesia and acute dystinic 
reactions are different (Marsden & Jenner, 
1980). It is, therefore, not necessary that both 
tardive dyskinesia and acute dystonia should 
have similar prevalence in manics and 
schizophrenics. 
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